Robust optimal control of polymorphic transformation in batch crystallization

AIChE Journal

Volumn 53, Issue 10, 2007, Pages 2643-2650

  Hermanto, Martin Wijaya ^a   Chiu, Min Sen ^a   Woo, Xing Yi ^a,b   Braatz, Richard D ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

C control; Pharmaceutical crystallization; Polymorphic transformation; Robust T control; T control

Indexed keywords

BIOAVAILABILITY; C CONTROL; PHARMACEUTICAL CRYSTALLIZATION; POLYMORPHIC TRANSFORMATION; ROBUST T CONTROL; T CONTROL;

FEEDBACK CONTROL; MOTIVATION; PHASE DIAGRAMS; POLYMORPHISM; RELIABILITY THEORY; ROBUSTNESS (CONTROL SYSTEMS); SYSTEMS ANALYSIS;

CRYSTALLIZATION;

CRYSTALLIZATION; FEEDBACK CONTROL; MOTIVATION; PHASE DIAGRAMS; POLYMORPHISM; RELIABILITY THEORY; ROBUSTNESS (CONTROL SYSTEMS); SYSTEMS ANALYSIS;

EID: 35248826975     PISSN: 00011541     EISSN: 15475905     Source Type: Journal    
DOI: 10.1002/aic.11266     Document Type: Article

References (29)

1. De Anda JC, Wang XZ, Lai X, Roberts KJ. Classifying organic crystals via in-process image analysis and the use of monitoring charts to follow polymorphic and morphological changes. J Process Contr. 2005:15:785-797.
2. Blagden N, Davey R. Polymorphs take shape. Chem Brit. 1999;35:44-47.
3. Fujiwara M, Nagy ZK, Chew JW, Braatz RD. First-principles and direct design approaches for the control of pharmaceutical crystallization. J Process Contr. 2005;15:493-504.
4. Rohani S, Home S, Murthy K. Control of product quality in batch crystallization of pharmaceuticals and fine chemicals. Part 1: Design of the crystallization process and the effect of solvent. Org Process Res Dev. 2005;9:858-872.
5. Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu HQ, Hussain AS. Applications of process analytical technology to crystallization processes. Adv Drug Delivery Rev. 2004;56:349-369.
6. Cardew PT, Davey RJ. The kinetics of solvent-mediated phase transformations. Proc R Soc Lond A. 1985:398:415-428.
7. Hu Q, Rohani S, Jutan A. Modelling and optimization of seeded batch crystallizers. Comput Chem Eng. 2005:29:911-918.
8. Larsen PA, Patience DB, Rawlings JB. Industrial crystallization process control. IEEE Contr Syst Mag. 2006;26:70-80.
9. Rawlings JB, Miller SM, Witkowski WR. Model identification and control of solution crystallization processes: A review. Ind Eng Chem Res. 1993;32:1275-1296.
10. Worlitschek J, Mazzotti M. Model-based optimization of particle size distribution in batch-cooling crystallization of paracetamol. Cryst Growth Des. 2004;4:891-903.
11. Zhang GP, Rohani S. On-line optimal control of a seeded batch cooling crystallizer. Chem Eng Sci. 2003;58:1887-1896.
12. vvBraatz RD, Fujiwara M, Wubben T, Rusli E. Crystallization: Particle size control. In: Swarbrick J, editor. Encyclopedia of Pharmaceutical Technology, 3rd ed. New York: Marcel Dekker, 2006:858-871 (invited).
13. Rohani S, Home S, Murthy K. Control of product quality in batch crystallization of pharmaceuticals and fine chemicals. Part 2: External control. Org Process Res Dev. 2005;9:873-883.
14. Diehl M, Bock HG, Kostina E. An approximation technique for robust nonlinear optimization, Math Program Ser B. 2006;107:213-230.
15. Ma DL, Braatz RD. Worst-case analysis of finite-time control policies. IEEE Trans Contr Syst Technol. 2001;9:766-774.
16. Srinivasan B, Bonvin D, Visser E, Palanki S, Dynamic optimization of batch processes - II. Role of measurements in handling uncertainty. Comput Chem Eng. 2003;27:27-44.
17. Fujiwara M, Chow PS, Ma DL, Braatz RD. Paracetamol crystallization using laser backscattering and ATR-FTIR spectroscopy: Metastability, agglomeration and control. Cryst Growth Des. 2002;2:363-370.
18. Gron H, Borissova A, Roberts KJ. In-process ATR-FTIR spectroscopy for closed-loop supersaturation control of a batch crystallizer producing monosodium glutamate crystals of defined size. Ind Eng Chem Res. 2003;42:198-206.
19. Liotta V, Sabesan V. Monitoring and feedback control of supersaturation using ATR-FTIR to produce an active pharmaceutical ingredient of a desired crystal size. Org Process Res Dev. 2004;8:488-494.
20. Brittain HG. The impact of polymorphism on drug development: A regulatory viewpoint. Am Pharmaceut Rev. 2000;3:67-70.
21. Ono T, Kramer HJM, Ter Horst JH, Jansens PJ. Process modeling of the polymorphic transformation of L-glutamic acid. Cryst Growth Des. 2004;4:1161-1167.
22. Miller SM, Rawlings JB. Model identification and control strategies for batch cooling crystallizers. AIChE J 1994;40:1312-1327.
23. Nagy ZK, Braatz RD. Worst-case and distributional robustness analysis of finite-time control trajectories for nonlinear distributed parameter systems. IEEE Trans Contr Syst Technol. 2003;11:694-704.
24. Hu Q, Rohani S, Wang DX, Jutan A. Optimal control of a batch cooling seeded crystallizer. Powder Technol. 2005;156:170-176.
25. Matthews HB, Rawlings JB. Batch crystallization of a photochemical: Modeling, control, and filtration. AIChE J. 1998;44:1119-1127.
26. Zhou GX, Fujiwara M, Woo XY, Rusli E, Tung HH, Starbuck C, Davidson O, Ge Z, Braatz RD. Direct design of pharmaceutical antisolvent crystallization through concentration control. Cryst Growth Des. 2006;6:892-898.
27. Kee N, Woo XY, Goh L, Chen K, He G, Bhamidi V, Rusli E, Nagy ZK, Kenis PJA, Zukoski CF, Tan RBH, Braatz RD. Design of crystallization processes from laboratory R&D to the manufacturing scale. Am Pharmaceut Rev. 2008;11:to appear.
28. Seborg DE, Henson MA, Nonlinear Process Control. 1st ed. Piscataway, NJ: Prentice Hall; 1996.
29. Togkalidou T, Fujiwara M, Patel S, Braatz RD. Solute concentration prediction using chemometrics and ATR-FTIR spectroscopy. J Cryst Growth. 2001;231:534-543.